Table 2.
Characteristics of cases of atrial fibrillation and controls
| Characteristics | Cases n = 726 |
Percent | Controls n = 7260 |
Percent | p value |
|---|---|---|---|---|---|
| Gender, female | 609 | 83.88 | 6090 | 83.88 | – |
| Agea | 76.9 ± 7.64 | 76.9 ± 7.65 | – | ||
| Age categories | |||||
| 55–65 years | 59 | 8.10 | 602 | 8.30 | |
| 66–75 years | 219 | 30.20 | 2155 | 29.70 | |
| 76–85 years | 361 | 49.70 | 3637 | 50.10 | |
| >85 years | 87 | 12.00 | 866 | 11.90 | |
| Cardiovascular diseases | |||||
| Angina pectoris | 203 | 27.96 | 1215 | 19.95 | <0.001* |
| Myocardial infarction | 20 | 2.75 | 92 | 1.51 | 0.001* |
| Heart failure | 80 | 11.02 | 199 | 3.27 | <0.001* |
| Antihypertensive drugs | 627 | 86.36 | 5186 | 85.16 | <0.001* |
| Diabetes mellitus | 84 | 11.57 | 780 | 12.81 | 0.494 |
| Estrogen/hormone replace therapy | 35 | 4.82 | 334 | 5.48 | 0.787 |
| Any type of fractures | 78 | 10.74 | 669 | 10.99 | 0.177 |
| Prior use of drugs | |||||
| Use of lipid lowering | 181 | 24.93 | 1497 | 20.62 | 0.007* |
| Oral corticosteroids | 271 | 37.33 | 2184 | 30.08 | <0.001* |
| Antithyroid | 18 | 2.48 | 87 | 1.20 | 0.004* |
*p < 0.05 (significant)
aThe data is mean ± standard deviation